This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why You Should Hold Synchrony (SYF) Stock in Your Portfolio
by Zacks Equity Research
Synchrony's (SYF) product innovations, partnerships and rising purchase volumes poise it well for growth.
Here's Why You Should Retain Rithm Capital (RITM) Stock for Now
by Zacks Equity Research
Rithm Capital's (RITM) asset management business expansion has tremendous growth potential ahead.
Houlihan Lokey (HLI) Ups Private Capital Mark With Triago Buyout
by Zacks Equity Research
Houlihan Lokey (HLI) expects the Triago Management acquisition to close in the first half of 2024.
Is Globe Life (GL) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Jefferies (JEF) Strengthens Canada Presence, Sets Up IB Unit
by Zacks Equity Research
Jefferies (JEF) strengthens its footprint in Canada with the new investment banking unit.
Compelling Reasons to Hold on to PRA Group (PRAA) Stock
by Zacks Equity Research
PRA Group (PRAA) is expected to capitalize on improving portfolio supply and pricing in the United States amid ongoing credit normalization.
Synchrony (SYF) & HABRI Join Forces to Boost Human-Animal Bond
by Zacks Equity Research
Synchrony (SYF) is expected to promote HABRI's science-based education within CareCredit's extensive veterinary network.
Why Investors Are Retaining American Express (AXP) Stock Now
by Zacks Equity Research
American Express' (AXP) both Billed Business and Processed Volumes are poised for sustained growth.
Synchrony (SYF) Frees Up Capital With the Sale of Pets Best
by Zacks Equity Research
Synchrony's (SYF) divestiture of Pets Best is expected to free up capital and expand Care Credit's reach to pet owners.
Reasons Why Globe Life (GL) Stock is an Attractive Pick Now
by Zacks Equity Research
Globe Life (GL) stands to gain from higher premiums, new investment yields, a strong liquidity position, favorable estimates and effective capital deployment.
Here's Why You Should Retain Principal Financial (PFG) Stock
by Zacks Equity Research
Principal Financial (PFG) remains well-poised to gain from strong retention and employment growth, higher single premium annuity sales and a solid capital position.
Why Is Globe Life (GL) Up 6.1% Since Last Earnings Report?
by Zacks Equity Research
Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synchrony (SYF) Joins Forces With Big Brand Tire & Service
by Zacks Equity Research
The new partnership will strategically expand Synchrony's (SYF) market reach in automotive financing.
Blue Owl Capital (OBDC) Q3 Earnings Beat, Dividend Raised
by Zacks Equity Research
Blue Owl Capital (OBDC) concludes the third quarter with investments in 187 portfolio companies, boasting an aggregate fair value of $12.9 billion.
Should Value Investors Consider Globe Life (GL) Stock?
by Zacks Equity Research
Is Globe Life (GL) a great pick from the value investor's perspective right now? Read on to know more.
Virtu Financial (VIRT) Falls 1.4% Despite Q3 Earnings Beat
by Zacks Equity Research
Virtu Financial's (VIRT) Market Making revenues jump 15.5% year over year in the third quarter.
Globe Life (GL) Q3 Earnings Top Estimates on Improved Premiums
by Zacks Equity Research
Globe Life (GL) expects net operating income between $10.49 per share and $10.65 per share for 2023.
Compared to Estimates, Globe Life (GL) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Globe Life (GL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Globe Life (GL) delivered earnings and revenue surprises of 2.26% and 0.07%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Synchrony (SYF) Q3 Earnings Beat on Growing Purchase Volume
by Zacks Equity Research
Synchrony (SYF) expects loan receivables to grow 11% for 2023, up from the previous guidance of 8-10%.
American Express (AXP) Tops on Q3 Earnings, Reaffirms View
by Zacks Equity Research
American Express (AXP) Q3 results reflect continued business momentum from strong card member spending and best-in-class credit performance.
Discover Financial (DFS) Q3 Earnings Miss on Higher Expenses
by Zacks Equity Research
Discover Financial's (DFS) Q3 results reflect poor performance of the Digital Banking segment and rising total expenses. Improving Payment Services segment partially offset the negatives.
Globe Life (GL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Globe Life (GL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing
by Zacks Equity Research
Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.
Should You Buy Globe Life (GL) Stock for Better Returns Now?
by Zacks Equity Research
Globe Life's (GL) higher premiums, new investment yields, strong liquidity position, favorable estimates and effective capital deployment poise it well for growth.